Advanced Enzyme Technologies Gears Up for Q3 Reveal on 31st January; Check Key Expectations Here

Click and Sign Up to Get Live Updates on Q3 Results 

Advanced Enzyme Technologies’s Q3 results FY26 are scheduled to be announced on 31st January 2026. Financial analysts anticipate an increase in revenue due to higher sales and a significant rise in PAT.

Advanced Enzyme Technologies Q3 Results 2026 Preview

• Advanced Enzyme Technologies’ revenue is expected to be in the range of ₹169.11 crore, a 15.75% YoY increase. 
• Profit After Tax, or PAT, is projected to rise by 14.66% YoY. 
• Net profit is ₹37.65 crore, a rise of 14.66% YoY 
• EBITDA to rise 38.06%

Advanced Enzyme Technologies Share Performance 

• Over the past six months, Advanced Enzyme Technologies’ share price has fallen by 8.95% to ₹28.00.
• Moreover, over the past year, the stock has increased by 12.87%.
• Despite this weak short-term performance, Advanced Enzyme Technologies’ stock has delivered a financially sound 239.85% return over the past 5 years.
• As of 29th January 2026, the stock traded at ₹28.00 per share.

Key Factors to Watch for Advanced Enzyme Technologies Q3 Results FY26 

• Revenue & Segment Growth: Check overall sales performance and how key verticals like Human Nutrition, Animal Nutrition, Bio‑Processing and Specialized Manufacturing are trending, as these diversifications drive topline strength.
• Profitability & Margins: Watch EBITDA and net profit margins, especially given recent cost pressures from raw materials and logistics that have affected margins in prior quarters.
• Order & Geographic Mix: Contribution from international markets vs domestic sales, including exports and region‑wise demand shifts, which can influence growth visibility.
• R&D & New Product Pipeline: Progress on R&D initiatives and new enzyme/probiotic solutions, including any new product launches or approvals that could catalyse future growth.
• Raw Material & Input Costs: Impact of raw material price volatility and supply‑chain issues on costs and margins — an important driver of operating performance.

Final Thoughts

Advanced Enzyme Technologies will announce its Q3 FY26 results on 30th January 2026. Analysts expect 4.30% YoY revenue growth, a 1.67% rise in PAT, and a 4.33% fall in EBITDA. Advanced Enzyme Technologies focuses on developing and supplying eco-friendly enzyme and probiotic solutions for healthcare, nutrition, and industrial applications globally.

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!

Recent Articles

Capital Small Finance Bank Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Carborundum Universal Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Capri Global Capital Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Digitide Solutions Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Flair Writing Industries Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

GHCL Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Apar Industries Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Apollo Pipes Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here